Blake Jeffrey Grayson Sells 15,588 Shares of DocuSign, Inc. (NASDAQ:DOCU) Stock

DocuSign, Inc. (NASDAQ:DOCUGet Free Report) CFO Blake Jeffrey Grayson sold 15,588 shares of the business’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total value of $1,524,194.64. Following the completion of the transaction, the chief financial officer now owns 85,851 shares in the company, valued at $8,394,510.78. This trade represents a 15.37 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Blake Jeffrey Grayson also recently made the following trade(s):

  • On Monday, December 16th, Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock. The shares were sold at an average price of $94.77, for a total value of $758,160.00.
  • On Tuesday, October 15th, Blake Jeffrey Grayson sold 9,552 shares of DocuSign stock. The stock was sold at an average price of $68.80, for a total transaction of $657,177.60.

DocuSign Trading Up 1.6 %

Shares of DocuSign stock opened at $94.15 on Friday. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The business’s 50 day simple moving average is $80.33 and its 200-day simple moving average is $64.43. The stock has a market capitalization of $19.02 billion, a price-to-earnings ratio of 19.41, a PEG ratio of 8.72 and a beta of 0.92.

Hedge Funds Weigh In On DocuSign

Hedge funds and other institutional investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign during the third quarter valued at about $28,000. Brooklyn Investment Group acquired a new stake in shares of DocuSign in the third quarter valued at $33,000. Reston Wealth Management LLC bought a new position in DocuSign during the third quarter valued at about $47,000. nVerses Capital LLC bought a new stake in DocuSign in the second quarter worth about $48,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in DocuSign in the 3rd quarter valued at about $51,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, December 6th. Jefferies Financial Group upped their target price on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. UBS Group boosted their price target on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. JMP Securities raised their price target on shares of DocuSign from $108.00 to $124.00 and gave the company a “market outperform” rating in a report on Friday, December 6th. Finally, Morgan Stanley increased their price objective on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $92.45.

Read Our Latest Report on DOCU

DocuSign Company Profile

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.